Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 304

    1.

    T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes.

    Pauza ME, Dobbs CM, He J, Patterson T, Wagner S, Anobile BS, Bradley BJ, Lo D, Haskins K.

    Diabetes. 2004 Apr;53(4):978-88.PMID: 15047613 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.

    Kanagawa O, Militech A, Vaupel BA.

    J Immunol. 2002 Jun 15;168(12):6159-64.PMID: 12055228 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    On the pathogenicity of autoantigen-specific T-cell receptors.

    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.

    Diabetes. 2008 May;57(5):1321-30. Epub 2008 Feb 25.PMID: 18299317 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.

    Jasinski JM, Yu L, Nakayama M, Li MM, Lipes MA, Eisenbarth GS, Liu E.

    Diabetes. 2006 Jul;55(7):1978-84.PMID: 16804066 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.

    Kanagawa O, Shimizu J, Vaupel BA.

    J Immunol. 2000 May 15;164(10):5466-73.PMID: 10799914 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.

    Serreze DV, Johnson EA, Chapman HD, Graser RT, Marron MP, DiLorenzo TP, Silveira P, Yoshimura Y, Nathenson SG, Joyce S.

    Diabetes. 2001 Sep;50(9):1992-2000.PMID: 11522664 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.

    Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, Kim SK, Dickie P, Teyton L, Davis M, McDevitt H.

    J Exp Med. 2002 Aug 19;196(4):481-92.PMID: 12186840 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Genetic and therapeutic control of diabetogenic CD8+ T cells.

    Santamaria P.

    Novartis Found Symp. 2008;292:130-6; discussion 136-45, 202-3.PMID: 19209463 [PubMed - indexed for MEDLINE]Related articles

    9.

    A diabetes-associated T-cell autoantigen maps to a telomeric locus on mouse chromosome 6.

    Dallas-Pedretti A, McDuffie M, Haskins K.

    Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1386-90.PMID: 7877988 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.

    Serreze DV, Choisy-Rossi CM, Grier AE, Holl TM, Chapman HD, Gahagan JR, Osborne MA, Zhang W, King BL, Brown A, Roopenian D, Marron MP.

    J Immunol. 2008 Mar 1;180(5):3250-9.PMID: 18292549 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.

    Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P.

    J Immunol. 2003 Dec 15;171(12):6900-9.PMID: 14662897 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors.

    Lipes MA, Rosenzweig A, Tan KN, Tanigawa G, Ladd D, Seidman JG, Eisenbarth GS.

    Science. 1993 Feb 19;259(5098):1165-9.PMID: 8267690 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rotavirus infection accelerates type 1 diabetes in mice with established insulitis.

    Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS.

    J Virol. 2008 Jul;82(13):6139-49. Epub 2008 Apr 16.PMID: 18417562 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.

    Roberts SA, Barbour G, Matarrese MR, Mason DL, Leiter EH, Haskins K, Hanson MS.

    J Autoimmun. 2003 Sep;21(2):139-47.PMID: 12935783 [PubMed - indexed for MEDLINE]Related articles

    17.

    Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.

    Graser RT, DiLorenzo TP, Wang F, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV.

    J Immunol. 2000 Apr 1;164(7):3913-8.PMID: 10725754 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

    Kupfer TM, Crawford ML, Pham K, Gill RG.

    J Immunol. 2005 Aug 15;175(4):2309-16.PMID: 16081800 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.

    Jun HS, Santamaria P, Lim HW, Zhang ML, Yoon JW.

    Diabetes. 1999 Jan;48(1):34-42.PMID: 9892220 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Following a diabetogenic T cell from genesis through pathogenesis.

    Katz JD, Wang B, Haskins K, Benoist C, Mathis D.

    Cell. 1993 Sep 24;74(6):1089-100.PMID: 8402882 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data